Prokidney (PROK) Long-Term Debt Issuances (2021 - 2022)

Prokidney's (PROK) quarterly Long-Term Debt Issuances came in at $15.0 million in Q2 2022, up 58395.5% year-on-year from N/an in Q2 2021, and down 25.0% on a QoQ basis from $20.0 million in Q1 2022.

Prokidney (PROK) Long-Term Debt Issuances (2021 - 2022) Analysis & Trends

Prokidney (PROK) has 2 years of Long-Term Debt Issuances data on file, last reported at $15.0 million in Q2 2022.

  • On a quarterly basis, Long-Term Debt Issuances rose 58395.5% year-over-year to $15.0 million in Q2 2022; TTM through Mar 2023 was $15.0 million, a 27.27% decrease from a year earlier, with the FY2022 full-year figure at $35.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances for Q2 2022 stood at $15.0 million, down from $20.0 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for PROK reached as high as $20.0 million in Q1 2022 and fell as low as $25643.0 in Q2 2021.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Prokidney 96.00 Mn 96.00 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 15.00 Mn
Jun 30, 2022 15.00 Mn
Mar 31, 2022 20.00 Mn
Mar 31, 2022 20.00 Mn
Dec 31, 2021 300,000.00
Dec 31, 2021 300,000.00
Sep 30, 2021 300,000.00
Sep 30, 2021 300,000.00
Jun 30, 2021 25,643.00
Jun 30, 2021 25,643.00